BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8320025)

  • 41. Interventions for erythema nodosum leprosum.
    Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rare atypical presentations in Type 2 lepra reaction: a case series.
    Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S
    Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lucio leprosy with lucio phenomenon.
    Saoji V; Salodkar A
    Indian J Lepr; 2001; 73(3):267-72. PubMed ID: 11840599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone profile in leprosy.
    Garg R; Agarwal JK; Singh G; Bajpai HS
    Indian J Lepr; 1989 Oct; 61(4):428-31. PubMed ID: 2516097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 48. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 49. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is pentoxifylline a viable alternative in the treatment of ENL?
    Sarno EN; Nery JA; Garcia CC; Sampaio EP
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.
    Putinatti MS; Lastória JC; Padovani CR
    An Bras Dermatol; 2014; 89(2):266-72. PubMed ID: 24770503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.
    Pisa P; Gennene M; Söder O; Ottenhoff T; Hansson M; Kiessling R
    J Infect Dis; 1990 May; 161(5):988-91. PubMed ID: 2324549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histoid leprosy with erythema nodosum leprosum--a case report.
    Vasavi S; Reddy BS
    Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokines in leprosy, I. Serum cytokine profile in leprosy.
    Moubasher AD; Kamel NA; Zedan H; Raheem DD
    Int J Dermatol; 1998 Oct; 37(10):733-40. PubMed ID: 9802682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 59. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

  • 60. A florid case of borderline-lepromatous leprosy.
    Raman J; Fisher D
    Med J Aust; 1988 Dec 5-19; 149(11-12):701-2. PubMed ID: 3200196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.